Both in Biotechnology
Kymera Therapeutics vs Vaxcyte
Over the past year KYMR returned +116.4% and PCVX returned +43.3%; their daily moves had a correlation of 0.29.
KYMR +116.4% PCVX +43.3%Growth of $1, one year, split-adjusted
| Metric | KYMR | PCVX |
|---|---|---|
| Price | $129.23 | $61.36 |
| Market cap | $11.03B | $9.66B |
| Today | +1.35% | +1.22% |
| 1 month | +17.6% | −16.9% |
| 6 months | +56.2% | +10.3% |
| Year to date | +66.1% | +33.0% |
| 1 year | +109.0% | +35.5% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 107.9× | — |
| Net cash | $969.2M | $1.49B |
| Dividend yield | — | — |
| Volatility (60d) | 38.9% | 70.7% |
| Short % of float | 13.7% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).